Why I favour axillary node clearance in the management of breast cancer
- 28 February 1995
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 21 (1) , 5-7
- https://doi.org/10.1016/s0748-7983(05)80057-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findingsAnnals of Surgical Oncology, 1994
- Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancerThe Lancet, 1992
- The role of axillary dissection in operable breast cancerThe Breast, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Axillary dissection in primary breast cancer.BMJ, 1991
- The axilla: not a no-go zoneThe Lancet, 1991
- Factors influencing local recurrence after excision and radiotherapy for primary breast cancerBritish Journal of Surgery, 1989
- Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP updateCancer, 1983
- THE INADEQUACY OF AXILLARY SAMPLING IN BREAST CANCERThe Lancet, 1982
- Ten-year results of the treatment of primary operable breast carcinoma.A summary of 304 patients evaluated by the TNM systemCancer, 1976